NCT01736397View on ClinicalTrials.gov

Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis

PHASE2CompletedINTERVENTIONAL
Enrollment

149

Participants

Timeline

Start Date

November 30, 2012

Primary Completion Date

November 30, 2013

Study Completion Date

December 31, 2013

Conditions
Iron DeficiencyIron Deficiency Anemia
Interventions
DRUG

Ferric Citrate

Dose depends on serum phosphorus levels collected at each study visit.

DRUG

Placebo

Trial Locations (20)

Unknown

Tempe

La Mesa

Sacramento

Denver

Edgewater

Miami

Meridian

Evergreen Park

Bethesda

Springfield

Detroit

Pontiac

Reno

Great Neck

Mineola

Asheville

Wilmington

Orangeburg

Houston

San Antonio

Sponsors
All Listed Sponsors
lead

Keryx Biopharmaceuticals

INDUSTRY

NCT01736397 - Ferric Citrate in Managing Serum Phosphorus and Iron Deficiency in Anemic Chronic Kidney Disease (CKD) Subjects Not on Dialysis | Biotech Hunter | Biotech Hunter